Sign in
CompletedPhase 1

Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

Key facts

Who runs it
Daewon Pharmaceutical Co., Ltd.
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1
People taking part
24 people enrolled
Started
21 Nov 2024
Ended
8 Apr 2025
Type of study
Interventional, 2 groups
Treatments tested
  • DW4421
Record updated
23 January 2026

Who can take part

Age
19 years to 50 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Healthy Volunteers who are ≥19 years old
  • Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2

Who cannot take part

  • Clinically significant Medical History
  • In the case of women, pregnant(Urine-HCG positive) or lactating women

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A Randomized, Open-label, Oral in healthy volunteers

The 2 groups in the trial

  • Sequence ATreatment being tested

    Cross-over

    Treatment: DW4421

  • Sequence BTreatment being tested

    Cross-over

    Treatment: DW4421

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase 1 Clinical Trial to Evaluate the Effect of Food on the Safety, Pharmacokinetics and Pharmacodynamics Characteristics of DW4421 in Healthy Adult Volunteers
Record updated
23 January 2026